Delesha Carpenter, PhD, MSPH, is a professor and Executive Vice Chair in the Division of Pharmaceutical Outcomes and Policy. Her research focuses on improving patient-provider communication about sensitive issues, like suicide and vaccine hesitancy. Recently, she documented barriers to community pharmacists delivering harm reduction services, including buprenorphine dispensing, naloxone counseling, and fentanyl test strip sales. She has developed four online training programs to help pharmacists overcome these barriers. She is especially interested in improving access to healthcare services in rural areas and directs a practice-based research network for rural community pharmacists. She also runs an active research program in inhaler technique education. She has developed an adolescent asthma self-management app and a tailored video software program to improve children’s asthma inhaler technique. She teaches the Social & Behavior Aspects of Pharmaceutical Use course and has enjoyed mentoring PhD students, PharmD students, and hosting students from other universities for research rotations. Carpenter has published more than 140 peer-reviewed articles on the topics of harm reduction, pediatric asthma, patient-provider communication, the effects of conflicting medication information on medication adherence, and evaluating the impact of technology on patient outcomes. She has received funding to support her research from a diverse body of funders, including the American Lung Association, American Foundation for Suicide Prevention, Arthritis Foundation, NIH, NSF, the Veteran’s Administration, and startup companies.